Sarepta have the most to lose and pride themselves as the owners of all things dmd. NS Pharma have already partnered with Crappy CAP. PTC dont have enough cash on hand. Sarepta are now cash positive and have $1.6B or so usd cash on hand. Doug Ingram stated big additions to their pipeline this year. Mark Diamond removed a video where he accidentally threw shade on Sareptas lack of results. Tox study due mid this year in most recent update and CY 2H 24 in company presso. Will Sarepta sign with us as soon as the tox is clear... I think so.
PER - Megathread, page-132
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.5¢ | 7.3¢ | $25.98K | 350.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15553 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 146315 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.001 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.5¢ | 7.3¢ | 48397 | ||
| Last updated 15.37pm 17/05/2024 ? | |||||
| PER (ASX) Chart |